Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ticagrelor effects on circulating microparticles and microRNAs in NSTE-ACS
2012-003897-21Phase 4Completed
- Sponsor
- Policlinico Gemelli
- Start
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of ticagrelor in acute coronary syndrome (ACS) and non–ST-segment elevation acute coronary syndrome (NSTE-ACS) (2 arms), sponsored by Policlinico Gemelli. Primary endpoint: Microparticle levels variation. Started Dec 2012; status: completed.
02
Drugs
ticagrelor
03
Conditions
acute coronary syndrome (ACS)non–ST-segment elevation acute coronary syndrome (NSTE-ACS)
Beyond the preview
Go deeper on 2012-003897-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-003897-21.